| RS1555690804 |
RAB11B
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with ataxic gait, absent speech |
| RS1555691353 |
MC4R
|
Health Risk |
Likely pathogenic |
— |
| RS1555691399 |
CYB5A
|
Health Risk |
Likely pathogenic |
Methemoglobinemia type 4, Methemoglobinemia type 4 |
| RS1555691402 |
MC4R
|
Health Risk |
Conflicting classifications of pathogenicity |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, Obesity |
| RS1555692916 |
PDE6G
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1555693029 |
ZBTB7A
|
Health Risk |
Pathogenic |
Macrocephaly, neurodevelopmental delay |
| RS1555693515 |
ATP8B1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1555693714 |
BPTF
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, Secondary microcephaly |
| RS1555694770 |
PIGN
|
Health Risk |
Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS1555695342 |
ATP5F1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Lactic acidosis, Mitochondrial complex V (ATP synthase) deficiency |
| RS1555696484 |
NFIX
|
Health Risk |
Pathogenic/Likely pathogenic |
Malan overgrowth syndrome, Marshall-Smith syndrome |
| RS1555696499 |
NFIX
|
Health Risk |
Pathogenic/Likely pathogenic |
Marshall-Smith syndrome, Inborn genetic diseases |
| RS1555696587 |
NFIX
|
Health Risk |
Pathogenic |
— |
| RS1555696597 |
NFIX
|
Health Risk |
Likely pathogenic |
Malan overgrowth syndrome, Marshall-Smith syndrome |
| RS1555696603 |
NFIX
|
Health Risk |
Pathogenic |
Malan overgrowth syndrome, NFIX-related disorder |
| RS1555696611 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, Malan overgrowth syndrome |
| RS1555696625 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, Marshall-Smith syndrome |
| RS1555696641 |
NFIX
|
Health Risk |
Likely pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS1555696660 |
NFIX
|
Health Risk |
Likely pathogenic |
— |
| RS1555696769 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS1555696933 |
MAP2K2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome and Noonan-related syndrome, Cardiovascular phenotype |
| RS1555697020 |
DOCK6
|
Health Risk |
Pathogenic/Likely pathogenic |
Adams-Oliver syndrome 2, Adams-Oliver syndrome 2 |
| RS1555699052 |
STRADA
|
Health Risk |
Pathogenic |
Self-limited epilepsy with centrotemporal spikes, Self-limited epilepsy with centrotemporal spikes |
| RS1555702147 |
GNA11
|
Health Risk |
Conflicting classifications of pathogenicity |
Lobular capillary hemangiomas, CLOVES syndrome |
| RS1555702261 |
GDF1
|
Health Risk |
Likely pathogenic |
Right atrial isomerism, Right atrial isomerism |
| RS1555703272 |
SLC25A10
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, Mitochondrial DNA depletion syndrome 19 |
| RS1555704436 |
RTTN
|
Health Risk |
Pathogenic |
— |
| RS1555705276 |
NFIX
|
Health Risk |
Pathogenic |
— |
| RS1555705733 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, Marshall-Smith syndrome |
| RS1555705966 |
SETBP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 29 |
| RS1555705992 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1555706137 |
MAN2B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1555706185 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1555706333 |
SETBP1
|
Health Risk |
Pathogenic |
— |
| RS1555706391 |
SETBP1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Intellectual disability |
| RS1555706476 |
SETBP1
|
Health Risk |
Pathogenic |
— |
| RS1555706499 |
SETBP1
|
Health Risk |
Pathogenic |
— |
| RS1555706596 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1555706706 |
MAN2B1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Deficiency of alpha-mannosidase |
| RS1555706752 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1555706774 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1555706928 |
SETBP1
|
Health Risk |
Likely pathogenic |
8 conditions, 8 conditions |
| RS1555707087 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1555707336 |
RTTN
|
Health Risk |
Pathogenic/Likely pathogenic |
MICROCEPHALY, SHORT STATURE |
| RS1555707363 |
NFIX
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555708126 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1555708156 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1555708227 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555708276 |
LONP1
|
Health Risk |
Likely pathogenic |
— |
| RS1555709349 |
ELANE
|
Health Risk |
Likely pathogenic |
— |
| RS1555709367 |
ELANE
|
Health Risk |
Likely pathogenic |
— |
| RS1555709533 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1555709893 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555709972 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1555710005 |
ELANE
|
Health Risk |
Pathogenic |
Cyclical neutropenia, Neutropenia |
| RS1555710069 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555710070 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1555710077 |
ELANE
|
Health Risk |
Likely pathogenic |
— |
| RS1555710089 |
ELANE
|
Health Risk |
Likely pathogenic |
Neutropenia, severe congenital |
| RS1555710107 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS1555710127 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555710171 |
TCF4
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555710223 |
TCF4
|
Health Risk |
Pathogenic |
Microcephaly, Pitt-Hopkins syndrome |
| RS1555710254 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1555710416 |
TCF4
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555710523 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555710726 |
TCF4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pitt-Hopkins syndrome, Inborn genetic diseases |
| RS1555710757 |
TCF4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555710813 |
TCF4
|
Health Risk |
Pathogenic/Likely pathogenic |
TCF4-related disorder, Pitt-Hopkins syndrome |
| RS1555710866 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS1555711142 |
TCF4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555711245 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555712474 |
TCF3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1555713236 |
LONP1
|
Health Risk |
Likely pathogenic |
— |
| RS1555713731 |
LONP1
|
Health Risk |
Likely pathogenic |
— |
| RS1555714808 |
C19orf12
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration with brain iron accumulation 4, Inborn genetic diseases |
| RS1555715029 |
LONP1
|
Health Risk |
Likely pathogenic |
— |
| RS1555715869 |
DNM2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease dominant intermediate B, Autosomal dominant centronuclear myopathy |
| RS1555716523 |
EPOR
|
Health Risk |
Likely pathogenic |
— |
| RS1555716575 |
GPX4
|
Health Risk |
Likely pathogenic |
Spondylometaphyseal dysplasia, Sedaghatian type |
| RS1555716802 |
TRMT1
|
Health Risk |
Likely pathogenic |
— |
| RS1555717153 |
RTTN
|
Health Risk |
Likely pathogenic |
— |
| RS1555717982 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555718063 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555718354 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555718410 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555718426 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555719172 |
TXNL4A
|
Health Risk |
Likely pathogenic |
Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome, Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome |
| RS1555719766 |
CLPP
|
Health Risk |
Pathogenic |
Perrault syndrome 3, Perrault syndrome 3 |
| RS1555719851 |
TYK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 35, Immunodeficiency 35 |
| RS1555719963 |
TYK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency 35, Immunodeficiency 35 |
| RS1555720521 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1555720728 |
SCN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 5, Brugada syndrome 5 |
| RS1555721549 |
SPTBN4
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, neuropathy |
| RS1555721815 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1555721837 |
ODAD3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Primary ciliary dyskinesia 30 |
| RS1555721921 |
TCF4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Pitt-Hopkins syndrome |
| RS1555722023 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555722264 |
NACC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS1555723585 |
WDR62
|
Health Risk |
Pathogenic |
Microcephaly 2, primary |